LUSCaR- Lund University Skin Cancer Research group
1 – 10 of 65
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
A First-In-Human Randomized Controlled Phase 1 Study Assessing the Safety and Tolerability of Topical TCP-25 Gel in Epidermal Suction Blister Wounds
- Contribution to journal › Article
-
Mark
Non-invasive Analysis of Skin in Recessive Dystrophic Epidermolysis Bullosa Using High-Frequency Ultrasound : A First Case Report
- Contribution to journal › Article
-
Mark
Modeling anti-tumor immune responses using patient-derived melanoma organoids
- Contribution to journal › Article
-
Mark
Image enhancements by CLAHE and gamma correction do not improve diagnostic accuracy in teledermoscopy: a retrospective cohort study
- Contribution to journal › Article
-
Mark
National Learning Objectives in Dermatology and Venereology for the New Swedish Medical Programme
- Contribution to journal › Article
- 2025
-
Mark
Prevalence of Hidradenitis Suppurativa in Lund and Gothenburg, Sweden : An Analysis from the Global Hidradenitis Suppurativa Atlas Initiative
(2025) In Dermatology
- Contribution to journal › Article
-
Mark
Does tattoo exposure increase the risk of cutaneous melanoma? A population-based case-control study
- Contribution to journal › Article
-
Mark
Contrasting Survival Outcomes and Patient Characteristics in 5,815 Patients with Stage II and III Melanoma : A Nationwide Population-Based Registry Study from Sweden
(2025) In The British journal of dermatology
- Contribution to journal › Article
-
Mark
Recovery from severe MDA5-associated dermatomyositis with only limited immunosuppression
- Contribution to journal › Letter
-
Mark
Results of a non-randomized, open-label phase I study evaluating the novel Immunomodulatory peptide TCP-25 for treatment of dystrophic epidermolysis bullosa
(2025) In Orphanet Journal of Rare Diseases
- Contribution to journal › Article
